Friday, June 19, 2026
World Drug Safety pharmaceutical event banner
← Back to Events
Tier 1 Global Networking: High GENERAL 117 DAYS AWAY

World Drug Safety — 2026 — Menino Convention Center, Boston, USA

Explore the top pharmacy conferences in 2026. Get executive insights on 340B reform, IRA drug pricing, and AI adoption from Asembia, ASHP, and THMA forums.

Menino Convention Center, Boston, USA October 14 – October 15, 2026
2,500+ Attendees
All Events

Presentation data updated Jun 5, 2026, 11:21 AM UTC

Why This Event Matters

Explore the top pharmacy conferences in 2026.

Industry impact

Explore the top pharmacy conferences in 2026.

Market implications

Expect signals on pricing, formulary strategy, and partnership economics relevant to general markets in the US region.

Regulatory implications

FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at general leadership forums.

Investor implications

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from World Drug Safety.

Competitive implications

Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

Event Significance

Tier-1 industry catalyst

36 /100 composite

World Drug Safety is a targeted general forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.

  • Media coverage 6/20

    Niche coverage — subscribe for direct abstract alerts.

  • Speaker quality 20/20

    Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.

  • Pipeline relevance 0/20

    Early science or services-focused — lower near-term PDUFA linkage.

  • Historical influence 10/20

    Some historical catalysts; compare readouts against last cycle.

  • Company participation 0/20

    Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.

Key Takeaways

Key Themes

generalPipeline announcementsPartnership deals

Key Markets

US Americas

Key Opportunities

Partnership dealsLicensing discussionsVendor selection

Timeline & Milestones

  1. Pre-event intelligence Upcoming

    Abstract discovery in progress; monitor Key Data tab.

  2. Conference opens Oct 14, 2026 Upcoming

    Live readouts, late-breakers, and partnership announcements.

  3. Live coverage window Upcoming

    Nova editorial monitors confirmed data releases.

  4. Conference closes Oct 15, 2026 Upcoming

    Post-event recap, competitive takeaways, and trial updates.

Best for
Investors & analysts

Executive Summary

C-level brief

Explore the top pharmacy conferences in 2026.

Primary audience: Investors & analysts

Analyst Watch

Investor desk

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from World Drug Safety.

Regulatory affairs

FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at general leadership forums.

Competitive intelligence

Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

vs. Prior Editions

Edition Presentations Companies
World Drug Safety (current) 0 0
Drug Discovery USA (2026) 2 0

Competitive Landscape

Company map →

Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

Coverage & Analysis

No coverage articles yet. Check back closer to the event.

Related News & Research

Research hub →

Event Intelligence Summary

Standalone summaries for World Drug Safety — optimized for research and AI retrieval.

Executive Summary

Explore the top pharmacy conferences in 2026.

Analyst View

Explore the top pharmacy conferences in 2026.

Investor View

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from World Drug Safety.

BD View

BD teams should prioritize networking with presenting companies and services vendors at World Drug Safety, focusing on general partnership and licensing opportunities.

Key Facts

Event
World Drug Safety
Focus
general
Region
US Americas
Attendance
2,500+

Ask Nova AI

AI-assisted answers grounded in NovaPharmaNews intelligence

Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.

Frequently Asked Questions

What is World Drug Safety?

World Drug Safety is a general industry conference bringing together executives, clinical leaders, and investors to discuss pipeline, regulatory, and commercial strategy.

Who attends World Drug Safety?

Typical attendees include pharma executives, BD teams, investors, regulatory affairs professionals, and clinical operations leaders focused on general.

Why is World Drug Safety important?

World Drug Safety influences partnership timing, pipeline prioritization, and policy debates that affect general markets for the next 12–18 months.

When is World Drug Safety?

World Drug Safety takes place on the scheduled dates.

Where is World Drug Safety held?

World Drug Safety is held in the listed venue.

How many attendees does World Drug Safety attract?

World Drug Safety typically draws 2,500+ attendees from across the general ecosystem.

What should investors watch at World Drug Safety?

Investors should track partnership announcements, pipeline readouts, M&A signals, and management commentary on general catalysts during and after World Drug Safety.

What BD opportunities exist at World Drug Safety?

BD teams use World Drug Safety for licensing discussions, co-development talks, and vendor selection across general — especially in networking sessions and satellite meetings.

How does World Drug Safety compare with other pharma conferences?

World Drug Safety is a tier-1 global congress for general — compare speaker quality, company participation, and historical deal flow with peer events in the same therapeutic or commercial vertical.

How do I get NovaPharmaNews coverage of World Drug Safety?

NovaPharmaNews publishes pre-event briefs, live coverage, and post-event analysis for World Drug Safety. Subscribe to event alerts on this page for breaking updates.

Intelligence Navigation